Clinical Trial Update: MRX, Radiation, and Chemotherapy for Patients With Resected Squamous Cell Carcinoma of the Head and Neck [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating MRX with radiation and chemotherapy for patients with resected head and neck squamous cell carcinoma was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• MRX

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Squamous Cell Carcinoma, Head and Neck Cancer | Phase 1 | Status: TERMINATED